<xmp id="swicy"><small id="swicy"></small>
  • <small id="swicy"></small><td id="swicy"><li id="swicy"></li></td>
  • <li id="swicy"></li>
  • <td id="swicy"></td>
  • <small id="swicy"></small>
  • CN / EN
    News center
    About us

    TechnoDerma Medicines Inc.

    Technoderma Medicines, Inc. is a privately held clinical stage biopharmaceutical company. The Company was originally located in Jiaxing Xiuzhou Biomedicine Guoqian Park, China, and recently relocated to Chengdu Tianfu BioPark, Sichuan, China.

    Its current core programs focus on development of innovative therapies for Androgenetic Alopecia, Atopic Dermatitis, Psoriasis and Lupus Erythematosus. Its "first-in-class" small molecule thyromimetic drug candidate TDM-105795 for Androgenetic Alopecia is currently completing Phase 2a clinical testing. Technoderma’s novel JAK1/TYK2 inhibitor TDM-180935 for Atopic Dermatitis has now completed Phase 1 clinical testing. The pipeline targets dermatologic indications.



    欧美激情一区二区三区成人,久草热线,亚洲欧美在线观看一区二区,三级欧美视频
    <xmp id="swicy"><small id="swicy"></small>
  • <small id="swicy"></small><td id="swicy"><li id="swicy"></li></td>
  • <li id="swicy"></li>
  • <td id="swicy"></td>
  • <small id="swicy"></small>